MEDROXYPROGESTERONE ACETATE
- Product NDC
- 50102-591
- 11-digit product format
- 501020591
- Labeler code
- 50102
- Product ID
- 50102-591_392ffaf7-c1c5-414a-8676-78f3cd4e24b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MEDROXYPROGESTERONE ACETATE
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Afaxys Pharma, LLC
- Application
- ANDA210761
- Marketing category
- ANDA
- Marketing start
- 2020-09-21
- Marketing end
- 0000-00-00
- Substance
- MEDROXYPROGESTERONE ACETATE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50102-591-40 | 50102059140 | 1 SYRINGE in 1 CARTON (50102-591-40) > 1 mL in 1 SYRINGE | 1 syringe | 2020-09-21 | 0000-00-00 | No | No | Current |